# Two newly released analyses of existing research have found no evidence that marijuana is … > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-efficacy-anxiety-depression-no-evidence/ > **Published:** 2026-03-17T02:04:52-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:06:19-04:00 > **Clinical Summary:** New analyses reveal cannabis efficacy anxiety depression is unsupported by current evidence, guiding clinicians to recommend proven treatments instead. --- ✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. AnxietyMental HealthResearchSafety Why This Matters These analyses provide clinicians with evidence-based guidance to avoid recommending cannabis for anxiety and depression, conditions where patients frequently self-medicate with marijuana despite lacking efficacy data. This clarification helps clinicians counsel patients on established treatments with proven effectiveness while reducing potential harms from [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) in vulnerable populations. The findings address a significant clinical knowledge gap, as patients often believe cannabis treats mental health symptoms when evidence does not support this use. Clinical Summary Recent systematic reviews of existing evidence have found insufficient data to support cannabis as an effective treatment for anxiety, depression, or other mental health conditions, with most available studies being small, poorly controlled, or at high risk of bias. These analyses highlight a significant gap between clinical use patterns and evidence-based recommendations, as many patients self-medicate with cannabis for psychiatric symptoms despite limited rigorous support for efficacy. The findings suggest that clinicians should exercise caution when patients present with cannabis use for mental health reasons, as the therapeutic benefit remains unproven and potential harms including symptom exacerbation or [cannabis use disorder](https://cedclinic.com/sex-differences-cannabis-stress-reactivity-oxytocin/) may be overlooked. Given the growing accessibility of cannabis products and patient interest in [alternative treatments](https://cedclinic.com/citral-cannabinoid-receptor-2-activation-pain-relief/) for anxiety and depression, clinicians need robust evidence-based guidance to counsel patients appropriately and consider established first-line psychiatric interventions. Practical takeaway: When patients inquire about or report using cannabis for anxiety or depression, clinicians should acknowledge the lack of supporting evidence, discuss potential risks, and recommend evidence-based treatments such as psychotherapy or pharmacotherapy with FDA-approved agents. Dr. Caplan’s Take “What we’re seeing in these analyses is actually clinically important: the evidence simply doesn’t support using cannabis as a first-line treatment for anxiety or depression, and patients need to know that anecdotal relief they might feel could easily be placebo or symptom masking rather than true therapeutic benefit. I counsel my patients that if they’re considering cannabis for mood or anxiety, it should only be after evidence-based treatments have been optimized, and then only with careful monitoring, because we’re not yet at a point where we can confidently say it’s helping their underlying condition.” Clinical Perspective While recent systematic reviews finding insufficient evidence for cannabis efficacy in anxiety and depression align with our limited high-quality clinical trial data, healthcare providers should recognize that many patients report subjective symptom relief and continue using cannabis for these conditions. The gap between patient-reported benefit and rigorous clinical evidence may reflect genuine therapeutic effects that current research methods haven’t adequately captured, placebo response, symptom fluctuation, or concurrent use of other treatments, making it difficult to counsel patients definitively. Additionally, cannabis’s effects are highly variable depending on cannabinoid ratios, dosing, route of administration, and individual factors like genetics and prior use patterns, which complicates the translation of population-level evidence to individual clinical decisions. Until higher-quality trials emerge, clinicians should avoid dismissing patients’ reported benefits while also refraining from recommending cannabis as a first-line treatment for anxiety or depression; instead, a collaborative approach that acknowledges current evidence 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/stress-management/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+Two+newly+released+analyses+of+existing+research+have+found+no+evidence+that+marijuana+is+...+%40drcaplan&url=https%3A%2F%2Fwww.facebook.com%2FWISHNews8%2Fposts%2Ftwo-newly-released-analyses-of-existing-research-have-found-no-evidence-that-mar%2F1353472483493271%2F)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fwww.facebook.com%2FWISHNews8%2Fposts%2Ftwo-newly-released-analyses-of-existing-research-have-found-no-evidence-that-mar%2F1353472483493271%2F)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+Two+newly+released+analyses+of+existing+research+have+found+no+evidence+that+marijuana+is+...+--+via+%40drcaplan.bsky.social+https%3A%2F%2Fwww.facebook.com%2FWISHNews8%2Fposts%2Ftwo-newly-released-analyses-of-existing-research-have-found-no-evidence-that-mar%2F1353472483493271%2F)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.facebook.com/WISHNews8/posts/two-newly-released-analyses-of-existing-research-have-found-no-evidence-that-mar/1353472483493271/](https://www.facebook.com/WISHNews8/posts/two-newly-released-analyses-of-existing-research-have-found-no-evidence-that-mar/1353472483493271/) Further Reading CED Clinic Blog[Why Cannabis Works](https://cedclinic.com/why-cannabis-works/) Evidence Watch[Cannabis and Heart Health](https://cedclinic.com/cannabis-cardiovascular-health-study/) CED Clinic Blog[Cannabis for Sleep](https://cedclinic.com/cannabis-for-sleep/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Can cannabis treat depression and anxiety? Here's what researchers found – MSN](https://cedclinic.com/medicinal-cannabis-depression-anxiety-ptsd-evidence-review/) Explore the latest research findings on cannabis use for depression and anxiety and what the evidence suggests about its effectiveness. [Read More](https://cedclinic.com/medicinal-cannabis-depression-anxiety-ptsd-evidence-review/) [Medical Cannabis and Anxiety in 2026: What Patients Need to Know Before Treatment](https://cedclinic.com/medical-cannabis-and-anxiety-in-2026-what-patients-need-to-know-before-treatment/) Important considerations and evidence-based advice for patients thinking about [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) for anxiety in 2026. [Learn More](https://cedclinic.com/medical-cannabis-and-anxiety-in-2026-what-patients-need-to-know-before-treatment/) [Is Cannabis Effective for Treating Mental Health Disorders? – Labroots](https://cedclinic.com/cannabis-mental-health-treatment-challenges/) A detailed review of cannabis effectiveness for various [mental health disorders](https://cedclinic.com/cannabinoid-receptor-type-2-schizophrenia/) based on current scientific evidence. [Discover Insights](https://cedclinic.com/cannabis-mental-health-treatment-challenges/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).